Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH¿AEG¿SEPD¿SEOM¿GETECCU Mar Riveiro-Barciela; Sabela Carballal; Álvaro Díaz-González; Míriam Mañosa; Javier Gallego-Plazas; Joaquín Cubiella; Paula Jiménez-Fonseca; María Varela; Luis Menchén; Bruno Sangro; Ana Fernández-Montes; Francisco Mesonero; Miguel Ángel Rodríguez-Gandía; Fernando Rivera; María-Carlota Londoño;

Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases Henrique C. Rocha; Eduardo G. Vilela;

Vedolizumab-induced cholestatic liver injury María Rojas-Feria; Miguel Rodríguez-Fernández; Manuel Castro-Fernández; Emilio Suárez-García;